KYMR logo

Kymera Therapeutics (KYMR) Operating expenses

annual operating expenses:

$303.78M+$59.66M(+24.44%)
December 31, 2024

Summary

  • As of today (July 1, 2025), KYMR annual total operating expenses is $303.78 million, with the most recent change of +$59.66 million (+24.44%) on December 31, 2024.
  • During the last 3 years, KYMR annual operating expenses has risen by +$130.42 million (+75.23%).
  • KYMR annual operating expenses is now at all-time high.

Performance

KYMR Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRincome statement metrics

quarterly operating expenses:

$96.53M+$8.38M(+9.50%)
March 31, 2025

Summary

  • As of today (July 1, 2025), KYMR quarterly total operating expenses is $96.53 million, with the most recent change of +$8.38 million (+9.50%) on March 31, 2025.
  • Over the past year, KYMR quarterly operating expenses has increased by +$33.33 million (+52.75%).
  • KYMR quarterly operating expenses is now at all-time high.

Performance

KYMR quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

KYMR Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+24.4%+52.8%
3 y3 years+75.2%+107.3%
5 y5 years+573.0%+557.8%

KYMR Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+75.2%at high+84.5%
5 y5-yearat high+573.0%at high+452.2%
alltimeall timeat high+1316.2%at high+653.5%

KYMR Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$96.53M(+9.5%)
Dec 2024
$303.78M(+24.4%)
$88.15M(+16.2%)
Sep 2024
-
$75.86M(-0.9%)
Jun 2024
-
$76.58M(+21.2%)
Mar 2024
-
$63.19M(-6.0%)
Dec 2023
$244.12M(+17.3%)
$67.20M(+8.0%)
Sep 2023
-
$62.24M(+3.9%)
Jun 2023
-
$59.90M(+9.3%)
Mar 2023
-
$54.79M(+0.0%)
Dec 2022
$208.08M
$54.77M(+0.6%)
Sep 2022
-
$54.43M(+4.0%)
Jun 2022
-
$52.32M(+12.4%)
DateAnnualQuarterly
Mar 2022
-
$46.55M(-5.5%)
Dec 2021
$173.36M(+115.8%)
$49.27M(+0.6%)
Sep 2021
-
$48.97M(+13.2%)
Jun 2021
-
$43.25M(+35.7%)
Mar 2021
-
$31.87M(+24.7%)
Dec 2020
$80.34M(+78.0%)
$25.57M(+13.0%)
Sep 2020
-
$22.62M(+29.4%)
Jun 2020
-
$17.48M(+19.1%)
Mar 2020
-
$14.68M(+7.8%)
Dec 2019
$45.14M(+110.4%)
$13.62M(+6.3%)
Sep 2019
-
$12.81M
Dec 2018
$21.45M
-

FAQ

  • What is Kymera Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Kymera Therapeutics?
  • What is Kymera Therapeutics annual operating expenses year-on-year change?
  • What is Kymera Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Kymera Therapeutics?
  • What is Kymera Therapeutics quarterly operating expenses year-on-year change?

What is Kymera Therapeutics annual total operating expenses?

The current annual operating expenses of KYMR is $303.78M

What is the all time high annual operating expenses for Kymera Therapeutics?

Kymera Therapeutics all-time high annual total operating expenses is $303.78M

What is Kymera Therapeutics annual operating expenses year-on-year change?

Over the past year, KYMR annual total operating expenses has changed by +$59.66M (+24.44%)

What is Kymera Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of KYMR is $96.53M

What is the all time high quarterly operating expenses for Kymera Therapeutics?

Kymera Therapeutics all-time high quarterly total operating expenses is $96.53M

What is Kymera Therapeutics quarterly operating expenses year-on-year change?

Over the past year, KYMR quarterly total operating expenses has changed by +$33.33M (+52.75%)
On this page